Jazz Pharma
JAZZ255.4300.61% ( +1.560 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Jazz Pharma(JAZZ) predict that the Revenue is 1.069 B (+19.05%), Beat estimate;the EBIT is 498.1 M (+154%), Beat estimate;the EPS is 4.43 (+391.5%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.07B19.05%
0.98B9.04%
+0.09B10.01%
EBITExceed expectations
0.50B154.02%
0.39B99.63%
+0.11B54.39%
EPSExceed expectations
4.43391.45%
1.828220.27%
+2.6020171.18%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 3, 2026
Estimate Revenue1.114 B
Estimate EBIT511.1 M
Estimate EPS3.1824
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf